292 related articles for article (PubMed ID: 24616445)
1. Serum-free spheroid suspension culture maintains mesenchymal stem cell proliferation and differentiation potential.
Alimperti S; Lei P; Wen Y; Tian J; Campbell AM; Andreadis ST
Biotechnol Prog; 2014; 30(4):974-83. PubMed ID: 24616445
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells.
Chase LG; Yang S; Zachar V; Yang Z; Lakshmipathy U; Bradford J; Boucher SE; Vemuri MC
Stem Cells Transl Med; 2012 Oct; 1(10):750-8. PubMed ID: 23197667
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Pluripotency, Differentiation, and Mitochondrial Metabolism Capacity in Three-Dimensional Spheroid Formation of Dental Pulp-Derived Mesenchymal Stem Cells.
Son YB; Bharti D; Kim SB; Jo CH; Bok EY; Lee SL; Kang YH; Rho GJ
Biomed Res Int; 2021; 2021():5540877. PubMed ID: 34337022
[TBL] [Abstract][Full Text] [Related]
4. Serum-free human MSC medium supports consistency in human but not in equine adipose-derived multipotent mesenchymal stromal cell culture.
Schubert S; Brehm W; Hillmann A; Burk J
Cytometry A; 2018 Jan; 93(1):60-72. PubMed ID: 28926198
[TBL] [Abstract][Full Text] [Related]
5. Production and Administration of Therapeutic Mesenchymal Stem/Stromal Cell (MSC) Spheroids Primed in 3-D Cultures Under Xeno-free Conditions.
Ylostalo JH; Bazhanov N; Mohammadipoor A; Bartosh TJ
J Vis Exp; 2017 Mar; (121):. PubMed ID: 28362380
[TBL] [Abstract][Full Text] [Related]
6. Isolation and prolonged expansion of oral mesenchymal stem cells under clinical-grade, GMP-compliant conditions differentially affects "stemness" properties.
Bakopoulou A; Apatzidou D; Aggelidou E; Gousopoulou E; Leyhausen G; Volk J; Kritis A; Koidis P; Geurtsen W
Stem Cell Res Ther; 2017 Nov; 8(1):247. PubMed ID: 29096714
[TBL] [Abstract][Full Text] [Related]
7. Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential.
Frith JE; Thomson B; Genever PG
Tissue Eng Part C Methods; 2010 Aug; 16(4):735-49. PubMed ID: 19811095
[TBL] [Abstract][Full Text] [Related]
8. Scaffold-free culture of mesenchymal stem cell spheroids in suspension preserves multilineage potential.
Baraniak PR; McDevitt TC
Cell Tissue Res; 2012 Mar; 347(3):701-11. PubMed ID: 21833761
[TBL] [Abstract][Full Text] [Related]
9. Culture of hybrid spheroids composed of calcium phosphate materials and mesenchymal stem cells on an oxygen-permeable culture device to predict in vivo bone forming capability.
Sato T; Anada T; Hamai R; Shiwaku Y; Tsuchiya K; Sakai S; Baba K; Sasaki K; Suzuki O
Acta Biomater; 2019 Apr; 88():477-490. PubMed ID: 30844570
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interplay between human MSCs and HUVECs in 3D spheroids laden in collagen/fibrin hydrogels for bone tissue engineering.
Heo DN; Hospodiuk M; Ozbolat IT
Acta Biomater; 2019 Sep; 95():348-356. PubMed ID: 30831326
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of 3D Culture Priming is Maintained in Human Mesenchymal Stem Cells after Extensive Expansion of the Cells.
Bartosh TJ; Ylostalo JH
Cells; 2019 Sep; 8(9):. PubMed ID: 31491901
[TBL] [Abstract][Full Text] [Related]
12. A novel serum-free medium for the expansion of human mesenchymal stem cells.
Chase LG; Lakshmipathy U; Solchaga LA; Rao MS; Vemuri MC
Stem Cell Res Ther; 2010 Apr; 1(1):8. PubMed ID: 20504289
[TBL] [Abstract][Full Text] [Related]
13. Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells.
Chen YS; Pelekanos RA; Ellis RL; Horne R; Wolvetang EJ; Fisk NM
Stem Cells Transl Med; 2012 Feb; 1(2):83-95. PubMed ID: 23197756
[TBL] [Abstract][Full Text] [Related]
14. Study on the Umbilical Cord-Mesenchymal Stem Cell Manufacturing Using Clinical-Grade Culture Medium.
Kurogi H; Takijiri T; Sakumoto M; Isogai M; Takahashi A; Okubo T; Koike T; Yamada T; Nagamura-Inoue T; Sakaki-Yumoto M
Tissue Eng Part C Methods; 2022 Jan; 28(1):23-33. PubMed ID: 35018815
[TBL] [Abstract][Full Text] [Related]
15. Unique characteristics of human mesenchymal stromal/progenitor cells pre-activated in 3-dimensional cultures under different conditions.
Ylostalo JH; Bartosh TJ; Tiblow A; Prockop DJ
Cytotherapy; 2014 Nov; 16(11):1486-1500. PubMed ID: 25231893
[TBL] [Abstract][Full Text] [Related]
16. Sub-confluent culture of human mesenchymal stromal cells on biodegradable polycaprolactone microcarriers enhances bone healing of rat calvarial defect.
Lam AT; Sim EJ; Shekaran A; Li J; Teo KL; Goggi JL; Reuveny S; Birch WR; Oh SK
Cytotherapy; 2019 Jun; 21(6):631-642. PubMed ID: 30975604
[TBL] [Abstract][Full Text] [Related]
17. Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions.
Santos Fd; Andrade PZ; Abecasis MM; Gimble JM; Chase LG; Campbell AM; Boucher S; Vemuri MC; Silva CL; Cabral JM
Tissue Eng Part C Methods; 2011 Dec; 17(12):1201-10. PubMed ID: 21895491
[TBL] [Abstract][Full Text] [Related]
18. Serum-free media formulations are cell line-specific and require optimization for microcarrier culture.
Tan KY; Teo KL; Lim JF; Chen AK; Choolani M; Reuveny S; Chan J; Oh SK
Cytotherapy; 2015 Aug; 17(8):1152-65. PubMed ID: 26139547
[TBL] [Abstract][Full Text] [Related]
19. Spheroid formation of mesenchymal stem cells on chitosan and chitosan-hyaluronan membranes.
Huang GS; Dai LG; Yen BL; Hsu SH
Biomaterials; 2011 Oct; 32(29):6929-45. PubMed ID: 21762982
[TBL] [Abstract][Full Text] [Related]
20. Standardized xeno- and serum-free culture platform enables large-scale expansion of high-quality mesenchymal stem/stromal cells from perinatal and adult tissue sources.
Hoang VT; Trinh QM; Phuong DTM; Bui HTH; Hang LM; Ngan NTH; Anh NTT; Nhi PY; Nhung TTH; Lien HT; Nguyen TD; Thanh LN; Hoang DM
Cytotherapy; 2021 Jan; 23(1):88-99. PubMed ID: 33097415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
